Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1981 1
1991 1
1992 3
1994 4
1995 5
1996 4
1997 7
1998 5
1999 8
2000 11
2001 7
2002 16
2003 5
2004 11
2005 12
2006 6
2007 14
2008 10
2009 18
2010 15
2011 8
2012 11
2013 15
2014 10
2015 10
2016 9
2017 13
2018 14
2019 9
2020 9
2021 18
2022 8
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L. Bjørklund G, et al. Autoimmun Rev. 2022 Aug;21(8):103135. doi: 10.1016/j.autrev.2022.103135. Epub 2022 Jun 9. Autoimmun Rev. 2022. PMID: 35690244 Review.
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-endocrine manifestations in childhood. ...The prevalence rate is highest in genetically isolated populations (up to 1:6500-1:9000). APS-1 oc
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-
Polyglandular autoimmune syndromes.
Kahaly GJ, Frommer L. Kahaly GJ, et al. J Endocrinol Invest. 2018 Jan;41(1):91-98. doi: 10.1007/s40618-017-0740-9. Epub 2017 Aug 17. J Endocrinol Invest. 2018. PMID: 28819917 Review.
METHODS: Review of the pertinent and current literature. RESULTS: Polyglandular autoimmune syndromes (PAS) are multifactorial diseases with at least two coexisting autoimmune-mediated endocrinopathies. PAS show a great heterogeneity of syndromes and manifest sequent …
METHODS: Review of the pertinent and current literature. RESULTS: Polyglandular autoimmune syndromes (PAS) are multifactorial disease …
Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge.
Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, Grymowicz M, Smolarczyk K, Kostrzak A, Smolarczyk R, Rudnicka E, Meczekalski B. Szeliga A, et al. Int J Mol Sci. 2021 Mar 5;22(5):2594. doi: 10.3390/ijms22052594. Int J Mol Sci. 2021. PMID: 33807517 Free PMC article. Review.
Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As the ovaries are a common target for autoimmune attacks, an autoimmune etiology of POI should always be considered, especially in the p …
Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As the ovar …
Autoimmune Polyendocrine Syndromes.
Husebye ES, Anderson MS, Kämpe O. Husebye ES, et al. N Engl J Med. 2018 Mar 22;378(12):1132-1141. doi: 10.1056/NEJMra1713301. N Engl J Med. 2018. PMID: 29562162 Free PMC article. Review. No abstract available.
Autoinmune polyendocrinopathy.
Fernández Miró M, Colom Comí C, Godoy Lorenzo R. Fernández Miró M, et al. Med Clin (Barc). 2021 Sep 10;157(5):241-246. doi: 10.1016/j.medcli.2021.02.004. Epub 2021 May 3. Med Clin (Barc). 2021. PMID: 33958142 Review. English, Spanish.
Pluriglandular autoimmune syndrome (APS) can affect multiple endocrine glands and is associated with other autoimmune diseases. ...SPA type 3 is characterized by autoimmune thyroid disease and other autoimmune disease, excluding Addison's disease and h …
Pluriglandular autoimmune syndrome (APS) can affect multiple endocrine glands and is associated with other autoimmune diseases …
Autoimmune polyglandular diseases.
Kahaly GJ, Frommer L. Kahaly GJ, et al. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101344. doi: 10.1016/j.beem.2019.101344. Epub 2019 Oct 4. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31606344 Review.
Autoimmune polyglandular diseases (APD) are defined as the presence of two autoimmune -induced endocrine failures. ...Considering the high incidence of one or more endocrinopathies in first-degree relatives of patients with APD, family members should be regularly sc
Autoimmune polyglandular diseases (APD) are defined as the presence of two autoimmune -induced endocrine failures. ...Consider
The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1).
Guo CJ, Leung PSC, Zhang W, Ma X, Gershwin ME. Guo CJ, et al. Autoimmun Rev. 2018 Jan;17(1):78-85. doi: 10.1016/j.autrev.2017.11.012. Epub 2017 Nov 4. Autoimmun Rev. 2018. PMID: 29108822 Review.
Autoimmune Polyglandular Syndrome type 1 (APS-1) is a subtype of the autoimmune polyendocrine syndrome characterized by the simultaneous or sequential dysfunction of multiple endocrine or non-endocrine glands. ...In this review, we provide a detailed critical overvi
Autoimmune Polyglandular Syndrome type 1 (APS-1) is a subtype of the autoimmune polyendocrine syndrome characterized by the si
Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.
Van den Driessche A, Eenkhoorn V, Van Gaal L, De Block C. Van den Driessche A, et al. Neth J Med. 2009 Dec;67(11):376-87. Neth J Med. 2009. PMID: 20009114 Free article. Review.
Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of insulin-producing beta cells and is characterised by the presence of insulitis and &and beta-cell autoantibodies. Up to one third of patients develop an autoimmune polyglandular syndrome. Fif …
Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of insulin-producing beta cells and is characterised by the prese …
Autoimmune enteropathies.
Umetsu SE, Brown I, Langner C, Lauwers GY. Umetsu SE, et al. Virchows Arch. 2018 Jan;472(1):55-66. doi: 10.1007/s00428-017-2243-7. Epub 2017 Oct 11. Virchows Arch. 2018. PMID: 29022145 Review.
Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea and immune-mediated injury of the intestinal mucosa. As the clinical and histopathologic manifestations of this disease are highly variable, its diagnosis is challenging for both clinici
Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea and immune-mediated injury of the intestinal m
ICPis-Induced Autoimmune Polyendocrine Syndrome Type 2: A Review of the Literature and a Protocol for Optimal Management.
Shi Y, Shen M, Zheng X, Chen Y, Zhao R, Gu Y, Yang T. Shi Y, et al. J Clin Endocrinol Metab. 2020 Dec 1;105(12):dgaa553. doi: 10.1210/clinem/dgaa553. J Clin Endocrinol Metab. 2020. PMID: 32905579 Review.
However, ICPis therapy is associated with a risk of immune-related adverse events (irAEs). Autoimmune polyendocrine syndrome type 2 (APS-2) is a rare endocrine irAE. ...CONCLUSIONS: Given the life-threatening risks of endocrine dysfunction if it is not promptly recognized …
However, ICPis therapy is associated with a risk of immune-related adverse events (irAEs). Autoimmune polyendocrine syndrome type 2 ( …
284 results